Global Drugs for Treating Mental Disorders Key Trends and Opportunities to 2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Drugs for Treating Mental Disorders Market Size by Type: 2016 VS 2021 VS 2027
  • 1.2.2 Tablets
  • 1.2.3 Capsule
  • 1.2.4 Injection
  • 1.2.5 Solution
  • 1.2.6 Other
• 1.3 Market by Application
  • 1.3.1 Global Drugs for Treating Mental Disorders Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Antipsychotics
  • 1.3.3 Antidepressants
  • 1.3.4 Antianxiety (Anxiolyitcs)
  • 1.3.5 Anti-Seizure Medications
  • 1.3.6 Stimulants
  • 1.3.7 Cognitive Disorders And Dementia
  • 1.3.8 Sleep Disorder Treatments
  • 1.3.9 Substance Abuse Treatments
  • 1.3.10 Hypnosis And Tranquilizers
  • 1.3.11 Other
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trend

• 2.1 Global Drugs for Treating Mental Disorders Market Perspective (2016-2027)
• 2.2 Global Drugs for Treating Mental Disorders Growth Trends by Regions
  • 2.2.1 Drugs for Treating Mental Disorders Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 Drugs for Treating Mental Disorders Historic Market Size by Regions (2016-2021)
  • 2.2.3 Drugs for Treating Mental Disorders Forecasted Market Size by Regions (2022-2027)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Drugs for Treating Mental Disorders Industry Trends
  • 2.3.2 Drugs for Treating Mental Disorders Market Drivers
  • 2.3.3 Drugs for Treating Mental Disorders Market Challenges
  • 2.3.4 Drugs for Treating Mental Disorders Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Drugs for Treating Mental Disorders Players by Market Size
  • 3.1.1 Players Covered: Ranking by Drugs for Treating Mental Disorders Revenue
  • 3.1.2 Global Top Drugs for Treating Mental Disorders Players by Revenue (2016-2021)
  • 3.1.3 Global Drugs for Treating Mental Disorders Revenue Market Share by Players (2016-2021)
  • 3.1.4 Global Drugs for Treating Mental Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.2 Global Drugs for Treating Mental Disorders Market Concentration Ratio
  • 3.2.1 Global Drugs for Treating Mental Disorders Market Concentration Ratio (CR5 and HHI)
  • 3.2.2 Global Top 5 and Top 10 Players by Drugs for Treating Mental Disorders Revenue in 2020
• 3.3 Drugs for Treating Mental Disorders Key Players Head office and Area Served
• 3.4 Key Players Drugs for Treating Mental Disorders Product Solution and Service
• 3.5 Date of Enter into Drugs for Treating Mental Disorders Market
• 3.6 Mergers & Acquisitions, Expansion Plans

4 Global Drugs for Treating Mental Disorders Breakdown Data by Type (2016-2027)

• 4.1 Global Drugs for Treating Mental Disorders Historic Market Size by Type (2016-2021)
• 4.2 Global Drugs for Treating Mental Disorders Forecasted Market Size by Type (2022-2027)

5 Global Drugs for Treating Mental Disorders Breakdown Data by Application (2016-2027)

• 5.1 Global Drugs for Treating Mental Disorders Historic Market Size by Application (2016-2021)
• 5.2 Drugs for Treating Mental Disorders Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America Drugs for Treating Mental Disorders Market Size (2016-2027)
• 6.2 Key Drugs for Treating Mental Disorders Players Market Share in North America (2020-2021)
• 6.3 North America Drugs for Treating Mental Disorders Market Size by Country
  • 6.3.1 North America Drugs for Treating Mental Disorders Sales by Country (2016-2021)
  • 6.3.2 North America Drugs for Treating Mental Disorders Market Size Forecast by Country (2022-2027)
• 6.4 U.S. Market Size Analysis
  • 6.4.1 U.S. Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 6.4.2 U.S. Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 6.4.3 U.S. Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 6.5 Canada Market Size Analysis
  • 6.5.1 Canada Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 6.5.2 Canada Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 6.5.3 Canada Drugs for Treating Mental Disorders Market Size by Application (2016-2027)

7 Europe

• 7.1 Europe Drugs for Treating Mental Disorders Market Size (2016-2027)
• 7.2 Key Drugs for Treating Mental Disorders Players Market Share in Europe (2020-2021)
• 7.3 Europe Drugs for Treating Mental Disorders Market Size by Country
  • 7.3.1 Europe Drugs for Treating Mental Disorders Sales by Country (2016-2021)
  • 7.3.2 Europe Drugs for Treating Mental Disorders Market Size Forecast by Country (2022-2027)
• 7.4 Germany Market Size Analysis
  • 7.4.1 Germany Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 7.4.2 Germany Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 7.4.3 Germany Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 7.5 France Market Size Analysis
  • 7.5.1 France Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 7.5.2 France Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 7.5.3 France Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 7.6 U.K. Market Size Analysis
  • 7.6.1 U.K. Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 7.6.2 U.K. Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 7.6.3 U.K. Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 7.7 Italy Market Size Analysis
  • 7.7.1 Italy Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 7.7.2 Italy Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 7.7.3 Italy Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 7.8 Russia Market Size Analysis
  • 7.8.1 Russia Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 7.8.2 Russia Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 7.8.3 Russia Drugs for Treating Mental Disorders Market Size by Application (2016-2027)

8 Asia-Pacific

• 8.1 Asia-Pacific Drugs for Treating Mental Disorders Market Size (2016-2027)
• 8.2 Key Drugs for Treating Mental Disorders Players Market Share in Asia-Pacific (2020-2021)
• 8.3 Asia-Pacific Drugs for Treating Mental Disorders Market Size by Region
  • 8.3.1 Asia-Pacific Drugs for Treating Mental Disorders Sales by Region (2016-2021)
  • 8.3.2 Asia-Pacific Drugs for Treating Mental Disorders Market Size Forecast by Region (2022-2027)
• 8.4 China Market Size Analysis
  • 8.4.1 China Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 8.4.2 China Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 8.4.3 China Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 8.5 Japan Market Size Analysis
  • 8.5.1 Japan Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 8.5.2 Japan Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 8.5.3 Japan Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 8.6 South Korea Market Size Analysis
  • 8.6.1 South Korea Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 8.6.2 South Korea Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 8.6.3 South Korea Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 8.7 India Market Size Analysis
  • 8.7.1 India Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 8.7.2 India Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 8.7.3 India Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 8.8 Australia Market Size Analysis
  • 8.8.1 Australia Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 8.8.2 Australia Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 8.8.3 Australia Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 8.9 Taiwan Market Size Analysis
  • 8.9.1 Taiwan Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 8.9.2 Taiwan Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 8.9.3 Taiwan Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 8.10 Indonesia Market Size Analysis
  • 8.10.1 Indonesia Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 8.10.2 Indonesia Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 8.10.3 Indonesia Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 8.11 Thailand Market Size Analysis
  • 8.11.1 Thailand Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 8.11.2 Thailand Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 8.11.3 Thailand Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 8.12 Malaysia Market Size Analysis
  • 8.12.1 Malaysia Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 8.12.2 Malaysia Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 8.12.3 Malaysia Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 8.13 Philippines Market Size Analysis
  • 8.13.1 Philippines Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 8.13.2 Philippines Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 8.13.3 Philippines Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 8.14 Vietnam Market Size Analysis
  • 8.14.1 Vietnam Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 8.14.2 Vietnam Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 8.14.3 Vietnam Drugs for Treating Mental Disorders Market Size by Application (2016-2027)

9 Latin America

• 9.1 Latin America Drugs for Treating Mental Disorders Market Size (2016-2027)
• 9.2 Key Drugs for Treating Mental Disorders Players Market Share in Latin America (2020-2021)
• 9.3 Latin America Drugs for Treating Mental Disorders Market Size by Country
  • 9.3.1 Latin America Drugs for Treating Mental Disorders Sales by Country (2016-2021)
  • 9.3.2 Latin America Drugs for Treating Mental Disorders Market Size Forecast by Country (2022-2027)
• 9.4 Mexico Market Size Analysis
  • 9.4.1 Mexico Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 9.4.2 Mexico Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 9.4.3 Mexico Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 9.5 Brazil Market Size Analysis
  • 9.5.1 Brazil Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 9.5.2 Brazil Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 9.5.3 Brazil Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 9.6 Argentina Market Size Analysis
  • 9.6.1 Argentina Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 9.6.2 Argentina Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 9.6.3 Argentina Drugs for Treating Mental Disorders Market Size by Application (2016-2027)

10 Middle East & Africa

• 10.1 Middle East & Africa Drugs for Treating Mental Disorders Market Size (2016-2027)
• 10.2 Key Drugs for Treating Mental Disorders Players Market Share in Middle East & Africa (2020-2021)
• 10.3 Middle East & Africa Drugs for Treating Mental Disorders Market Size by Country
  • 10.3.1 Middle East & Africa Drugs for Treating Mental Disorders Sales by Country (2016-2021)
  • 10.3.2 Middle East & Africa Drugs for Treating Mental Disorders Market Size Forecast by Country (2022-2027)
• 10.4 Turkey Market Size Analysis
  • 10.4.1 Turkey Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 10.4.2 Turkey Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 10.4.3 Turkey Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 10.5 Saudi Arabia Market Size Analysis
  • 10.5.1 Saudi Arabia Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 10.5.2 Saudi Arabia Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 10.5.3 Saudi Arabia Drugs for Treating Mental Disorders Market Size by Application (2016-2027)
• 10.6 UAE Market Size Analysis
  • 10.6.1 UAE Drugs for Treating Mental Disorders Market Size (2016-2027)
  • 10.6.2 UAE Drugs for Treating Mental Disorders Market Size by Type (2016-2027)
  • 10.6.3 UAE Drugs for Treating Mental Disorders Market Size by Application (2016-2027)

11 Key Players Profiles

• 11.1 Johnson and Johnson
  • 11.1.1 Johnson and Johnson Company Details
  • 11.1.2 Johnson and Johnson Business Overview and Its Total Revenue
  • 11.1.3 Johnson and Johnson Drugs for Treating Mental Disorders Introduction
  • 11.1.4 Johnson and Johnson Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.1.5 Johnson and Johnson Recent Development
• 11.2 Pfizer
  • 11.2.1 Pfizer Company Details
  • 11.2.2 Pfizer Business Overview and Its Total Revenue
  • 11.2.3 Pfizer Drugs for Treating Mental Disorders Introduction
  • 11.2.4 Pfizer Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.2.5 Pfizer Recent Development
• 11.3 Eli Lilly
  • 11.3.1 Eli Lilly Company Details
  • 11.3.2 Eli Lilly Business Overview and Its Total Revenue
  • 11.3.3 Eli Lilly Drugs for Treating Mental Disorders Introduction
  • 11.3.4 Eli Lilly Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.3.5 Eli Lilly Recent Development
• 11.4 GlaxoSmithKline
  • 11.4.1 GlaxoSmithKline Company Details
  • 11.4.2 GlaxoSmithKline Business Overview and Its Total Revenue
  • 11.4.3 GlaxoSmithKline Drugs for Treating Mental Disorders Introduction
  • 11.4.4 GlaxoSmithKline Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.4.5 GlaxoSmithKline Recent Development
• 11.5 AstraZeneca
  • 11.5.1 AstraZeneca Company Details
  • 11.5.2 AstraZeneca Business Overview and Its Total Revenue
  • 11.5.3 AstraZeneca Drugs for Treating Mental Disorders Introduction
  • 11.5.4 AstraZeneca Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.5.5 AstraZeneca Recent Development
• 11.6 Bristol-Myers Squibb
  • 11.6.1 Bristol-Myers Squibb Company Details
  • 11.6.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  • 11.6.3 Bristol-Myers Squibb Drugs for Treating Mental Disorders Introduction
  • 11.6.4 Bristol-Myers Squibb Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.6.5 Bristol-Myers Squibb Recent Development
• 11.7 Teva Pharmaceutical
  • 11.7.1 Teva Pharmaceutical Company Details
  • 11.7.2 Teva Pharmaceutical Business Overview and Its Total Revenue
  • 11.7.3 Teva Pharmaceutical Drugs for Treating Mental Disorders Introduction
  • 11.7.4 Teva Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.7.5 Teva Pharmaceutical Recent Development
• 11.8 Dr. Reddy's Laboratories
  • 11.8.1 Dr. Reddy's Laboratories Company Details
  • 11.8.2 Dr. Reddy's Laboratories Business Overview and Its Total Revenue
  • 11.8.3 Dr. Reddy's Laboratories Drugs for Treating Mental Disorders Introduction
  • 11.8.4 Dr. Reddy's Laboratories Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.8.5 Dr. Reddy's Laboratories Recent Development
• 11.9 Apotex Inc.
  • 11.9.1 Apotex Inc. Company Details
  • 11.9.2 Apotex Inc. Business Overview and Its Total Revenue
  • 11.9.3 Apotex Inc. Drugs for Treating Mental Disorders Introduction
  • 11.9.4 Apotex Inc. Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.9.5 Apotex Inc. Recent Development
• 11.10 Mylan Pharmaceuticals
  • 11.10.1 Mylan Pharmaceuticals Company Details
  • 11.10.2 Mylan Pharmaceuticals Business Overview and Its Total Revenue
  • 11.10.3 Mylan Pharmaceuticals Drugs for Treating Mental Disorders Introduction
  • 11.10.4 Mylan Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.10.5 Mylan Pharmaceuticals Recent Development
• 11.11 Par Pharmaceutical
  • 11.11.1 Par Pharmaceutical Company Details
  • 11.11.2 Par Pharmaceutical Business Overview and Its Total Revenue
  • 11.11.3 Par Pharmaceutical Drugs for Treating Mental Disorders Introduction
  • 11.11.4 Par Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.11.5 Par Pharmaceutical Recent Development
• 11.12 Aurobindo Pharma
  • 11.12.1 Aurobindo Pharma Company Details
  • 11.12.2 Aurobindo Pharma Business Overview and Its Total Revenue
  • 11.12.3 Aurobindo Pharma Drugs for Treating Mental Disorders Introduction
  • 11.12.4 Aurobindo Pharma Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.12.5 Aurobindo Pharma Recent Development
• 11.13 Torrent Pharmaceuticals
  • 11.13.1 Torrent Pharmaceuticals Company Details
  • 11.13.2 Torrent Pharmaceuticals Business Overview and Its Total Revenue
  • 11.13.3 Torrent Pharmaceuticals Drugs for Treating Mental Disorders Introduction
  • 11.13.4 Torrent Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.13.5 Torrent Pharmaceuticals Recent Development
• 11.14 Jubilant Lifesciences
  • 11.14.1 Jubilant Lifesciences Company Details
  • 11.14.2 Jubilant Lifesciences Business Overview and Its Total Revenue
  • 11.14.3 Jubilant Lifesciences Drugs for Treating Mental Disorders Introduction
  • 11.14.4 Jubilant Lifesciences Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.14.5 Jubilant Lifesciences Recent Development
• 11.15 Sun Pharmaceutical
  • 11.15.1 Sun Pharmaceutical Company Details
  • 11.15.2 Sun Pharmaceutical Business Overview and Its Total Revenue
  • 11.15.3 Sun Pharmaceutical Drugs for Treating Mental Disorders Introduction
  • 11.15.4 Sun Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.15.5 Sun Pharmaceutical Recent Development
• 11.16 Sandoz (Novartis)
  • 11.16.1 Sandoz (Novartis) Company Details
  • 11.16.2 Sandoz (Novartis) Business Overview and Its Total Revenue
  • 11.16.3 Sandoz (Novartis) Drugs for Treating Mental Disorders Introduction
  • 11.16.4 Sandoz (Novartis) Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.16.5 Sandoz (Novartis) Recent Development
• 11.17 Hansoh Pharmaceutical
  • 11.17.1 Hansoh Pharmaceutical Company Details
  • 11.17.2 Hansoh Pharmaceutical Business Overview and Its Total Revenue
  • 11.17.3 Hansoh Pharmaceutical Drugs for Treating Mental Disorders Introduction
  • 11.17.4 Hansoh Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.17.5 Hansoh Pharmaceutical Recent Development
• 11.18 WATSON Pharmaceuticals
  • 11.18.1 WATSON Pharmaceuticals Company Details
  • 11.18.2 WATSON Pharmaceuticals Business Overview and Its Total Revenue
  • 11.18.3 WATSON Pharmaceuticals Drugs for Treating Mental Disorders Introduction
  • 11.18.4 WATSON Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.18.5 WATSON Pharmaceuticals Recent Development
• 11.19 Zhejiang Langhua Pharmaceuticals
  • 11.19.1 Zhejiang Langhua Pharmaceuticals Company Details
  • 11.19.2 Zhejiang Langhua Pharmaceuticals Business Overview and Its Total Revenue
  • 11.19.3 Zhejiang Langhua Pharmaceuticals Drugs for Treating Mental Disorders Introduction
  • 11.19.4 Zhejiang Langhua Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.19.5 Zhejiang Langhua Pharmaceuticals Recent Development
• 11.20 Forest Laboratories
  • 11.20.1 Forest Laboratories Company Details
  • 11.20.2 Forest Laboratories Business Overview and Its Total Revenue
  • 11.20.3 Forest Laboratories Drugs for Treating Mental Disorders Introduction
  • 11.20.4 Forest Laboratories Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.20.5 Forest Laboratories Recent Development
• 11.21 H.Lundbeck A/S
  • 11.21.1 H.Lundbeck A/S Company Details
  • 11.21.2 H.Lundbeck A/S Business Overview and Its Total Revenue
  • 11.21.3 H.Lundbeck A/S Drugs for Treating Mental Disorders Introduction
  • 11.21.4 H.Lundbeck A/S Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.21.5 H.Lundbeck A/S Recent Development
• 11.22 Amneal Pharmaceuticals
  • 11.22.1 Amneal Pharmaceuticals Company Details
  • 11.22.2 Amneal Pharmaceuticals Business Overview and Its Total Revenue
  • 11.22.3 Amneal Pharmaceuticals Drugs for Treating Mental Disorders Introduction
  • 11.22.4 Amneal Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.22.5 Amneal Pharmaceuticals Recent Development
• 11.23 Hetero Drugs
  • 11.23.1 Hetero Drugs Company Details
  • 11.23.2 Hetero Drugs Business Overview and Its Total Revenue
  • 11.23.3 Hetero Drugs Drugs for Treating Mental Disorders Introduction
  • 11.23.4 Hetero Drugs Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.23.5 Hetero Drugs Recent Development
• 11.24 Macleods Pharmaceuticals
  • 11.24.1 Macleods Pharmaceuticals Company Details
  • 11.24.2 Macleods Pharmaceuticals Business Overview and Its Total Revenue
  • 11.24.3 Macleods Pharmaceuticals Drugs for Treating Mental Disorders Introduction
  • 11.24.4 Macleods Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.24.5 Macleods Pharmaceuticals Recent Development
• 11.25 Silarx Pharmacueticals
  • 11.25.1 Silarx Pharmacueticals Company Details
  • 11.25.2 Silarx Pharmacueticals Business Overview and Its Total Revenue
  • 11.25.3 Silarx Pharmacueticals Drugs for Treating Mental Disorders Introduction
  • 11.25.4 Silarx Pharmacueticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.25.5 Silarx Pharmacueticals Recent Development
• 11.26 Hikma Pharmaceuticals
  • 11.26.1 Hikma Pharmaceuticals Company Details
  • 11.26.2 Hikma Pharmaceuticals Business Overview and Its Total Revenue
  • 11.26.3 Hikma Pharmaceuticals Drugs for Treating Mental Disorders Introduction
  • 11.26.4 Hikma Pharmaceuticals Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.26.5 Hikma Pharmaceuticals Recent Development
• 11.27 Lupin Limited
  • 11.27.1 Lupin Limited Company Details
  • 11.27.2 Lupin Limited Business Overview and Its Total Revenue
  • 11.27.3 Lupin Limited Drugs for Treating Mental Disorders Introduction
  • 11.27.4 Lupin Limited Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.27.5 Lupin Limited Recent Development
• 11.28 Prinston Pharmaceutical
  • 11.28.1 Prinston Pharmaceutical Company Details
  • 11.28.2 Prinston Pharmaceutical Business Overview and Its Total Revenue
  • 11.28.3 Prinston Pharmaceutical Drugs for Treating Mental Disorders Introduction
  • 11.28.4 Prinston Pharmaceutical Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.28.5 Prinston Pharmaceutical Recent Development
• 11.29 STI Pharma
  • 11.29.1 STI Pharma Company Details
  • 11.29.2 STI Pharma Business Overview and Its Total Revenue
  • 11.29.3 STI Pharma Drugs for Treating Mental Disorders Introduction
  • 11.29.4 STI Pharma Revenue in Drugs for Treating Mental Disorders Business (2016-2021)
  • 11.29.5 STI Pharma Recent Development

12 Analyst's Viewpoints/Conclusion

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source